{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:50:00Z","timestamp":1793433000603,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biopha.2018.11.117","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T22:56:04Z","timestamp":1544568964000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats"],"prefix":"10.1016","volume":"110","author":[{"given":"Aly M.","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf Al","family":"Suleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Al","family":"Za'abi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarsini","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Nemmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1836-6348","authenticated-orcid":false,"given":"Nicole","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreldin H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.11.117_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000108755","article-title":"Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China","volume":"28","author":"Xie","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0010","first-page":"229","article-title":"Addressing the global burden of chronic kidney disease through clinical and translational research","volume":"125","author":"Ojo","year":"2014","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.biopha.2018.11.117_bib0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/ndt\/gfw315","article-title":"Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients","volume":"32","author":"Tokoroyama","year":"2017","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.biopha.2018.11.117_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MNH.0b013e328335f939","article-title":"Health-related quality of life outcomes in chronic kidney disease","volume":"19","author":"Soni","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2018.11.117_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ndt\/gfx341","article-title":"Uric acid in chronic kidney disease: the quest for causality continues","volume":"33","author":"Zoccali","year":"2018","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.biopha.2018.11.117_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-5876-9-13","article-title":"Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications","volume":"9","author":"L\u00f3pez-Novoa","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.11.117_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nep.13180","article-title":"Adenine-induced chronic kidney disease in rats","volume":"23","author":"Diwan","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2018.11.117_bib0040","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.biopha.2018.02.143","article-title":"Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats","volume":"101","author":"Thakur","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.11.117_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fct.2013.12.038","article-title":"The effect of activated charcoal on adenine-induced chronic renal failure in rats","volume":"65","author":"Ali","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.numecd.2016.03.002","article-title":"DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives","volume":"26","author":"Bonora","year":"2016","journal-title":"Nutr. Metab. Cardiovas. Dis."},{"key":"10.1016\/j.biopha.2018.11.117_bib0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.numecd.2016.01.001","article-title":"Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury","volume":"26","author":"Penno","year":"2016","journal-title":"Nutr. Meta. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2018.11.117_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/aps.2014.98","article-title":"Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors","volume":"36","author":"Chang","year":"2015","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.11.117_bib0065","first-page":"2784","article-title":"Sitagliptin ameliorates diabetic nephropathy by blocking TGF-\u03b21\/Smad signaling pathway","volume":"5","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.11.117_bib0070","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.biopha.2017.10.107","article-title":"The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice","volume":"97","author":"Al Suleimani","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.11.117_bib0075","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.3390\/ijms150711416","article-title":"The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.11.117_bib0080","article-title":"Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells","volume":"12","author":"Choi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.11.117_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000370","article-title":"Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease","volume":"3","author":"Nelson","year":"2016","journal-title":"Open. Heart"},{"key":"10.1016\/j.biopha.2018.11.117_bib0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrd.2016.67","article-title":"The next generation of therapeutics for chronic kidney disease","volume":"15","author":"Breyer","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2018.11.117_bib0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.semnephrol.2016.05.009","article-title":"Established and emerging strategies in the treatment of chronic kidney disease","volume":"36","author":"Pena-Polanco","year":"2016","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.11.117_bib0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2013.10.033","article-title":"Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor","volume":"720","author":"Abd El Motteleb","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125285","article-title":"Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.11.117_bib0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1139\/cjpp-2015-0364","article-title":"Renoprotective effects of aliskiren on adenine-induced tubulointerstitial nephropathy: possible underlying mechanisms","volume":"92","author":"Hussein","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0120","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.phymed.2011.03.005","article-title":"Effect of Acacia gum on blood pressure in rats with adenine-induced chronic renal failure","volume":"18","author":"Ali","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2018.11.117_bib0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12882-017-0742-z","article-title":"Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency","volume":"18","author":"T\u00f6rm\u00e4nen","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0130","doi-asserted-by":"crossref","first-page":"F333","DOI":"10.1152\/ajprenal.00285.2013","article-title":"Impaired renal function and development in Belgrade rats","volume":"306","author":"Veuthey","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bcpt.12817","article-title":"Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease","volume":"122","author":"Ali","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0140","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.biopha.2018.11.117_bib0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vascn.2013.05.006","article-title":"Adenine-induced chronic kidney and cardiovascular damage in rats","volume":"68","author":"Diwan","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.biopha.2018.11.117_bib0150","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant \u03b1-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.11.117_bib0155","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00209.2014","article-title":"Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system","volume":"307","author":"Aroor","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-018-0704-1","article-title":"The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin","volume":"17","author":"Aroor","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcjd.2014.05.001","article-title":"Blood pressure-lowering effects of incretin-based diabetes therapies","volume":"38","author":"Lovshin","year":"2014","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.biopha.2018.11.117_bib0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-014-0157-0","article-title":"DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure","volume":"13","author":"Koibuchi","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0091270008316885","article-title":"Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension","volume":"48","author":"Mistry","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.223.133","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes","volume":"223","author":"Ogawa","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.biopha.2018.11.117_bib0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/HJH.0b013e328341939d","article-title":"Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats","volume":"29","author":"Pacheco","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2018.11.117_bib0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31826be204","article-title":"Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats","volume":"60","author":"Mason","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0195","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats","volume":"154","author":"Aroor","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2018.11.117_bib0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/hr.2014.173","article-title":"Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats","volume":"38","author":"Sufiun","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.biopha.2018.11.117_bib0205","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/HJH.0000000000000328","article-title":"Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy","volume":"32","author":"Sharkovska","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2018.11.117_bib0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.114.04631","article-title":"Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent","volume":"65","author":"Jackson","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.11.117_bib0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00210-017-1367-2","article-title":"Sitagliptin exerts anti-apoptotic effect in nephrotoxicity induced by cisplatin in rats","volume":"390","author":"Abdelrahman","year":"2017","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2018.11.117_bib0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2015.04.023","article-title":"Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats","volume":"761","author":"Sakai","year":"2015","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218367970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218367970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:25:08Z","timestamp":1764105908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218367970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"alternative-id":["S0753332218367970"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.117","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}